Hypoglossal nerve neoplasm

Summary

Hypoglossal nerve neoplasm (MONDO:0002550) is a cancer. A subtype of hypoglossal nerve disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	hypoglossal nerve neoplasm
Mondo ID	MONDO:0002550
DOID	DOID:3198
NCIT	C5830
SNOMED CT	126978008
UMLS	C1263903
MedGen	220392
Anatomy (UBERON)	UBERON:0001650
Is cancer (heuristic)	yes

Also known as: hypoglossal nerve neoplasm · hypoglossal nerve neoplasm (disease) · hypoglossal nerve neoplasms · hypoglossal nerve tumor · hypoglossal nerve tumors · hypoglossal nerve tumour · hypoglossal nerve tumours · neoplasm of hypoglossal nerve · neoplasm of the hypoglossal nerve · neoplasm of the twelfth cranial nerve · neoplasm of twelfth cranial nerve · tumor of hypoglossal nerve · tumor of the hypoglossal nerve · tumor of the twelfth cranial nerve · tumor of twelfth cranial nerve · tumour of hypoglossal nerve · tumour of the hypoglossal nerve · tumour of the twelfth cranial nerve · tumour of twelfth cranial nerve · twelfth cranial nerve neoplasm (+8 more)

Disease family

An umbrella term covering 1 Mondo subtype.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › cranial nerve neuropathy › hypoglossal nerve disorder › hypoglossal nerve neoplasm

Subtypes (1): schwannoma of twelfth cranial nerve

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.